Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Hematol Oncol ; 44(1): e56-e61, 2022 01 01.
Article in English | MEDLINE | ID: mdl-34001783

ABSTRACT

We used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to evaluate a Stroke Prevention Team's readiness to prevent strokes in children with sickle cell anemia living in northern Nigeria. The NIH sponsored Stroke Prevention Trial in Nigeria included a goal of a sustainable stroke prevention program. The program's 1-year reach for transcranial Doppler screening was 14.7% (4710/32,000) of which 6.0% (281/4710) had abnormal velocities (≥200 cm/s). All participants with abnormal transcranial Doppler velocities were started on hydroxyurea (effectiveness). The leaders of all 5 hospitals agreed to adopt the program. After 1 year, program-implementation and maintenance rates were 100%, demonstrating the program's feasibility and short-term sustainability.


Subject(s)
Anemia, Sickle Cell , Antisickling Agents/administration & dosage , Hydroxyurea/administration & dosage , Stroke , Anemia, Sickle Cell/complications , Anemia, Sickle Cell/drug therapy , Anemia, Sickle Cell/epidemiology , Child , Child, Preschool , Female , Humans , Male , Nigeria/epidemiology , Program Evaluation , Stroke/epidemiology , Stroke/etiology , Stroke/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...